Skip to main content

Table 4 Comparison of significant infection responses identified with SAS Proc Mixed LMMA or the non-parametric Wilcoxon signed rank test.

From: Infection and genotype remodel the entire soybean transcriptome

Data Pre-Processinga

Genotype

Infection Responseb

Wilcoxonc

LMMAd

Number Matchesg

Percentage matchesh

   

Significante

% sigf

Significant

% sig

  

GC-RMA

V71-370

Upper vs. Mock

23,016

81.2

20,418

72.0

20,406

99.94

  

Lower vs. Mock

23,739

83.7

21,772

76.8

21,749

99.89

 

Sloan

Upper vs. Mock

24,369

86

22,758

80.3

22,712

99.8

  

Lower vs. Mock

24,872

87.7

23,556

83.1

23,513

99.82

 

VPRIL9

Upper vs. Mock

24,851

87.7

23,543

83.0

23,482

99.74

  

Lower vs. Mock

25,260

89.1

24,180

85.3

24,087

99.62

MAS5

V71-370

Upper vs. Mock

22,300

78.7

19,486

68.7

19,478

99.96

  

Lower vs. Mock

23,406

82.6

21,772

74.8

21,189

99.96

 

Sloan

Upper vs. Mock

23,984

84.6

22,758

78.5

22,208

99.82

  

Lower vs. Mock

24,578

86.7

23,556

81.7

23,153

99.94

 

VPRIL9

Upper vs. Mock

24,714

87.2

23,543

82.5

23,366

99.91

  

Lower vs. Mock

25,144

88.7

24,180

85.4

24,165

99.81

  1. aThe data used for the analyses were either preprocessed using GC-RMA or using MAS5 algorithm as described in the Methods. bInfection responses relative to mock-inoculated tissue were evaluated for the upper infection court (Upper vs. Mock) and the lower infection court (Lower vs. Mock). cWilcoxon signed ranks test implemented by the wilcox.test function of R package stats version 2.6.0. dLinear mixed model analysis performed in SAS Proc Mixed. Model: y = Genotype + Treatment + Time + Genotype × Treatment + Block + Block × Genotype + Block × Treatment + Block × Time + Block × Genotype × Treatment + Error, where y refers to the log2 scale median polish summarized gene expression values, the main factors (Genotype, Treatment and Time) and the interaction Genotype × Treatment were fixed factors while all the remaining terms were random factors. eTotal number of significant genes with TST-FDR adjusted p ≤ 0.01. fPercentage of the total number of detectable genes that are significant. gNumber of significant genes found with both Wilcoxon and LMMA. hThe number of matches found with both methods, as a percentage of the total number of significant genes found by Wilcoxon or LMMA, whichever was smaller.